Comparison Overview

Hepro.us

VS

BD

Hepro.us

325 East 10th Court, Hialeah, Florida, 33010, US
Last Update: 2025-03-07 (UTC)
Between 900 and 1000
http://www.hepro.us

Excellent

Our company is FDA licensed and our brand name is registered with the US Patent and Trademark office and market quality products.We distribute wholesale disposable medical supplies such as Syringes, Gloves, Glucose-meters, Test Strips, etc. Here at HEPRO.US we want to give you the highest quality products at the best price, making health-care more affordable.

NAICS: 339
NAICS Definition:
Employees: 4
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

BD

1 Becton Drive, Franklin Lakes, New Jersey, 07417, US
Last Update: 2025-03-04 (UTC)

Strong

Between 800 and 900
http://www.bd.com

BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 43,786
Subsidiaries: 6
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/hepro-us.jpeg
Hepro.us
—
ISO 27001
Not verified
—
SOC 2
Not verified
—
GDPR
No public badge
—
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/bd1.jpeg
BD
—
ISO 27001
Not verified
—
SOC 2
Not verified
—
GDPR
No public badge
—
PCI DSS
No public badge
Compliance Summary
Hepro.us
100%
Compliance Rate
0/4 Standards Verified
BD
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Hepro.us in 2025.

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for BD in 2025.

Incident History — Hepro.us (X = Date, Y = Severity)

Hepro.us cyber incidents detection timeline including parent company and subsidiaries

Incident History — BD (X = Date, Y = Severity)

BD cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/hepro-us.jpeg
Hepro.us
Incidents

No Incident

https://images.rankiteo.com/companyimages/bd1.jpeg
BD
Incidents

No Incident

FAQ

Hepro.us company company demonstrates a stronger AI risk posture compared to BD company company, reflecting its advanced AI governance and monitoring frameworks.

Historically, BD company has disclosed a higher number of cyber incidents compared to Hepro.us company.

In the current year, BD company and Hepro.us company have not reported any cyber incidents.

Neither BD company nor Hepro.us company has reported experiencing a ransomware attack publicly.

Neither BD company nor Hepro.us company has reported experiencing a data breach publicly.

Neither BD company nor Hepro.us company has reported experiencing targeted cyberattacks publicly.

Neither Hepro.us company nor BD company has reported experiencing or disclosing vulnerabilities publicly.

BD company has more subsidiaries worldwide compared to Hepro.us company.

BD company employs more people globally than Hepro.us company, reflecting its scale as a Medical Equipment Manufacturing.

Latest Global CVEs (Not Company-Specific)

Description

An issue was discovered in chinabugotech hutool before 5.8.4 allowing attackers to execute arbitrary expressions that lead to arbitrary method invocation and potentially remote code execution (RCE) via the QLExpressEngine class.

Published
Date
2025-09-25
Updated
Date
2025-09-25
References
Description

A weakness has been identified in JeecgBoot up to 3.8.2. The impacted element is an unknown function of the file /sys/role/exportXls. This manipulation causes improper authorization. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Published
Date
2025-09-25
Updated
Date
2025-09-25
Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

A security flaw has been discovered in JeecgBoot up to 3.8.2. The affected element is an unknown function of the file /sys/user/exportXls of the component Filter Handler. The manipulation results in improper authorization. The attack may be performed from remote. The exploit has been released to the public and may be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Published
Date
2025-09-25
Updated
Date
2025-09-25
Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

A vulnerability was identified in JeecgBoot up to 3.8.2. Impacted is an unknown function of the file /sys/tenant/deleteBatch. The manipulation of the argument ids leads to improper authorization. The attack is possible to be carried out remotely. The complexity of an attack is rather high. The exploitability is considered difficult. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published
Date
2025-09-25
Updated
Date
2025-09-25
Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

A vulnerability was determined in JeecgBoot up to 3.8.2. This issue affects some unknown processing of the file /api/getDepartUserList. Executing manipulation of the argument departId can lead to improper authorization. The attack can be executed remotely. This attack is characterized by high complexity. The exploitability is assessed as difficult. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

Published
Date
2025-09-25
Updated
Date
2025-09-25
Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References